Detailed View
EW - Edwards Lifesciences Corporatio
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
48,648,159,232
Adj EBIT (TTM)
1,821,900,000
Enterprise Value
45,101,059,232
Last Price
84.40
Earnings Yield
4.04%
Return on Capital
20.19%
Capital
9,025,400,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 1,741,000,000 | 513,200,000 |
| 2026-03-31 | 10-Q | 2026 | 1,648,600,000 | 477,600,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 1,569,600,000 | 356,000,000 |
| 2025-09-30 | 10-Q | 2025 | 1,553,100,000 | 307,100,000 |
| 2025-06-30 | 10-Q | 2025 | 1,532,200,000 | 411,200,000 |
| 2025-03-31 | 10-Q | 2025 | 1,412,700,000 | 394,800,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 1,101,000,000 | 271,500,000 |
| 2024-09-30 | 10-Q | 2024 | 1,354,400,000 | 350,600,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.